91 related articles for article (PubMed ID: 7607504)
41. Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues.
Wright NA; Poulsom R; Stamp GW; Hall PA; Jeffery RE; Longcroft JM; Rio MC; Tomasetto C; Chambon P
J Pathol; 1990 Dec; 162(4):279-84. PubMed ID: 2290113
[TBL] [Abstract][Full Text] [Related]
42. Expression of an estrogen-induced breast cancer-associated protein (pS2) in benign and malignant human ovarian cysts.
Dante R; Ribieras S; Baldassini S; Martin V; Benzerara O; Bouteille C; Brémond A; Frappart L; Rio MC; Lasne Y
Lab Invest; 1994 Aug; 71(2):188-92. PubMed ID: 8078298
[TBL] [Abstract][Full Text] [Related]
43. Methylation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells.
Arapshian A; Kuppumbatti YS; Mira-y-Lopez R
Oncogene; 2000 Aug; 19(35):4066-70. PubMed ID: 10962564
[TBL] [Abstract][Full Text] [Related]
44. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence.
Berry M; Nunez AM; Chambon P
Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1218-22. PubMed ID: 2919170
[TBL] [Abstract][Full Text] [Related]
45. Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells.
Chalbos D; Philips A; Galtier F; Rochefort H
Endocrinology; 1993 Aug; 133(2):571-6. PubMed ID: 8344199
[TBL] [Abstract][Full Text] [Related]
46. Association of the human spasmolytic polypeptide and an estrogen-induced breast cancer protein (pS2) with human pancreatic carcinoma.
Welter C; Theisinger B; Seitz G; Tomasetto C; Rio MC; Chambon P; Blin N
Lab Invest; 1992 Feb; 66(2):187-92. PubMed ID: 1735955
[TBL] [Abstract][Full Text] [Related]
47. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
48. Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced pS2 expression.
Zacharewski TR; Bondy KL; McDonell P; Wu ZF
Cancer Res; 1994 May; 54(10):2707-13. PubMed ID: 8168101
[TBL] [Abstract][Full Text] [Related]
49. MUC2 gene suppression in human colorectal carcinomas and their metastases: in vitro evidence of the modulatory role of DNA methylation.
Hanski C; Riede E; Gratchev A; Foss HD; Böhm C; Klussmann E; Hummel M; Mann B; Buhr HJ; Stein H; Kim YS; Gum J; Riecken EO
Lab Invest; 1997 Dec; 77(6):685-95. PubMed ID: 9426407
[TBL] [Abstract][Full Text] [Related]
50. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
51. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
[TBL] [Abstract][Full Text] [Related]
52. Methylation profiling of CpG islands in human breast cancer cells.
Huang TH; Perry MR; Laux DE
Hum Mol Genet; 1999 Mar; 8(3):459-70. PubMed ID: 9949205
[TBL] [Abstract][Full Text] [Related]
53. Modulation of proliferation, estradiol receptors and estrogen regulated protein PS2/BCEI in human breast cancer cell lines by gamma interferon.
Solary E; Prud'homme JF; Gauville C; Magdelenat H; Calvo F
J Biol Regul Homeost Agents; 1991; 5(3):98-106. PubMed ID: 1763658
[TBL] [Abstract][Full Text] [Related]
54. Transient cyclical methylation of promoter DNA.
Kangaspeska S; Stride B; Métivier R; Polycarpou-Schwarz M; Ibberson D; Carmouche RP; Benes V; Gannon F; Reid G
Nature; 2008 Mar; 452(7183):112-5. PubMed ID: 18322535
[TBL] [Abstract][Full Text] [Related]
55. Methylation in hMLH1 promoter interferes with its binding to transcription factor CBF and inhibits gene expression.
Deng G; Chen A; Pong E; Kim YS
Oncogene; 2001 Oct; 20(48):7120-7. PubMed ID: 11704838
[TBL] [Abstract][Full Text] [Related]
56. Production and comparison of mature single-domain 'trefoil' peptides pNR-2/pS2 Cys58 and pNR-2/pS2 Ser58.
Chadwick MP; May FE; Westley BR
Biochem J; 1995 Jun; 308 ( Pt 3)(Pt 3):1001-7. PubMed ID: 8948462
[TBL] [Abstract][Full Text] [Related]
57. Non-CpG cytosine methylation of p53 exon 5 in non-small cell lung carcinoma.
Kouidou S; Agidou T; Kyrkou A; Andreou A; Katopodi T; Georgiou E; Krikelis D; Dimitriadou A; Spanos P; Tsilikas C; Destouni H; Tzimagiorgis G
Lung Cancer; 2005 Dec; 50(3):299-307. PubMed ID: 16125822
[TBL] [Abstract][Full Text] [Related]
58. Expression of the oestrogen responsive protein pS2 in human breast cancer.
Balleine RL; Clarke CL
Histol Histopathol; 1999 Apr; 14(2):571-8. PubMed ID: 10212819
[TBL] [Abstract][Full Text] [Related]
59. Sequencing of the rat light neurofilament promoter reveals differences in methylation between expressing and non-expressing cell lines, but not tissues.
Reeben M; Myöhänen S; Saarma M; Prydz H
Gene; 1995 May; 157(1-2):325-9. PubMed ID: 7607521
[TBL] [Abstract][Full Text] [Related]
60. Genome-wide analysis and modeling of DNA methylation susceptibility in 30 breast cancer cell lines by using CpG flanking sequences.
An J; Kim K; Rhee SM; Chae H; Nephew KP; Kim S
J Bioinform Comput Biol; 2013 Jun; 11(3):1341003. PubMed ID: 23796180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
